Summary
James Coyne is a Principal Scientist with over nine years of experience developing and validating PK, PD, and immunogenicity assays for large biologics and AAV gene therapies in regulated GLP/GCLP environments. He combines deep bioanalytical, biochemistry, and engineering expertise with hands-on assay development, CRO management, and regulatory support to drive program decisions and successful transfers. James has a strong track record of implementing new analytical tools—such as DLS for biomolecule characterization—and championing digital innovation by integrating AI into bioanalytical workflows to accelerate data analysis. His academic background (PhD in Bioengineering from Penn State) underpins a history of translational work spanning drug delivery platforms, in vivo studies, and quantitative image analysis. Known for clear communication with senior stakeholders and clients, he also brings cross-disciplinary product sensibility from roles in scientific product strategy and innovation consulting. Based in Greater Philadelphia, he blends rigorous lab science with a curiosity for full-stack creative technology, reflected in his interest in UX and software development.
10 years of coding experience
9 years of employment as a software developer
Doctor of Philosophy, Bioengineering and Biomedical Engineering, Doctor of Philosophy, Bioengineering and Biomedical Engineering at Penn State University